St. Jude Medical (STJ) and Medtronic (MDT) are seeing increasing volume today, with turnover running five times normal and three times usual, respectively. Both stocks are higher after Friedman Billings analysts explained that upcoming changes to MedicareÃƒÂ¢Ã¢â€šÂ¬Ã¢â€žÂ¢s annual reimbursement adjustments could bode will for reimbursements on certain medical devices including pacemakers and defibrillators. STJ is up $1.42 to $45.50 amid increasing volume in April and May call options. MDT gained 82 cents to $49.84 and increasing interest is being seen in the April and November call options.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.